Fellow and Young Clinician Support

MSCO Travel Awards

The Massachusetts Society of Clinical Oncology (MSCO) is pleased to announce that as part of our efforts to support the growth and future of the oncology profession, we will be providing a grant for oncology professionals from Massachusetts to travel to the ASCO Annual Meeting.

Among the recipients of the MSCO Travel Award will be one fellow of an ACGME-accredited training program and one young clinician (with less than five years of practice).

The application deadline is April 1st. 

Download application and submission requirements

Thank you to everyone who applied. This years 2023 Travel Grants have been awarded to the following individuals:

• Jonathan Berry, MD, Clinical Fellow & Chief Fellow, Hematology and Oncology, Beth Israel Deaconess Medical Center, Boston, MA
• Pamela Contreras Chavez, MD, Hematology-Oncology Fellow, Dana-Farber Cancer Institute - Saint Elizabeth's Medical Center, Boston, MA; Clinical Advisor at the Center for Global Cancer Medicine, Dana-Farber Cancer Institute, Boston, MA
• Chidambaram Ramasamy, MD, Chief Medical Resident, Saint Vincent Hospital, Worcester, MA

We are thrilled that MSCO can support you in this endeavor and look forward to hearing about your experiences at the conference. Best wishes for a successful trip! 

MSCO's ASCO Young Investigator AWARD

The Massachusetts Society of Clinical Oncologists (MSCO) is proud to annually fund one Young Investigator Award (YIA) for a qualified Massachusetts applicant through Conquer Cancer, the ASCO Foundation. We encourage all eligible Massachusetts Fellows and Trainees to apply. The YIA is a one-year, $57,500 grant that provides research funding to promising physicians to support their transition from final years of subspecialty training to faculty appointment and to encourage and promote quality research in clinical oncology. For questions about eligibility, please contact Conquer Cancer at grants@conquer.org. 

2023 recipient

Arielle Medford, MD

Massachusetts General Hospital

“MDM2 inhibition for patients with hormone-receptor positive, GATA3-mutant metastatic breast cancer”

Mentored by: Aditya Bardia, MD, MPH and Leif Ellisen, MD, PhD

Past Award Recipients

2022

2021

A Phase 2 trial of palbociclib in combination with axitinib and avelumab in metastatic clear cell renal cell carcinoma.

Praful Ravi, MBBChir, MRCP, a Medical Oncologist at the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, is the recipient of the inaugural YIA Award supported by MSCO.